BioSpace News Archive

Novocure announced that it will participate in three upcoming investor conferences.

Shopko Optical Renews Commitment to High-Quality Eye Care Services Establishing New Free-Standing Optical Centers

PRV-031 Granted Breakthrough Therapy Designation for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals

Four significant microbiome program milestones expected during 2020, including readouts from two late-stage development programs

Conference Call and Webcast Today at 8:00 a.m. ET

Drug supply for compassionate use has been manufactured and is ready for use

Data to be presented at the Inaugural Conference on Brain Metastases, August 16-17, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that the Company has appointed Minnie Baylor-Henry to the Board of Directors, effective August 1, 2019

DarioHealth Corp. (Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference of the American Association of Diabetes Educators (AADE) in Houston, Texas on August 9-12, 2019.

Paladina Health, a healthcare provider of direct primary care services, today announced the appointment of Kirk Rosin, CEBS, as chief revenue officer.